25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ETON (Eton Pharmaceuticals Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Eton Pharmaceuticals Inc together

I guess you are interested in Eton Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Eton Pharmaceuticals Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Eton Pharmaceuticals Inc’s Price Targets

I'm going to help you getting a better view of Eton Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Eton Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Eton Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$0.91
Expected worth in 1 year
$1.24
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.33
Return On Investment
2.3%

For what price can you sell your share?

Current Price per Share
$14.45
Expected price per share
$11.09 - $21.48
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Eton Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$14.45
Intrinsic Value Per Share
$1.69 - $2.02
Total Value Per Share
$2.60 - $2.93

2.2. Growth of Eton Pharmaceuticals Inc (5 min.)




Is Eton Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$24.4m$16.1m$3.4m17.5%

How much money is Eton Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.1m$228.2k-$1.3m-119.9%
Net Profit Margin-10.4%-2.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Eton Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Eton Pharmaceuticals Inc?

Welcome investor! Eton Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Eton Pharmaceuticals Inc.

First you should know what it really means to hold a share of Eton Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Eton Pharmaceuticals Inc is $14.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eton Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eton Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.91. Based on the TTM, the Book Value Change Per Share is $0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eton Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-0.4%-0.04-0.3%0.010.1%-0.03-0.2%-0.07-0.5%-0.14-0.9%
Usd Book Value Change Per Share0.000.0%0.080.6%0.040.3%0.030.2%0.030.2%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.080.6%0.040.3%0.030.2%0.030.2%0.030.2%
Usd Price Per Share12.98-8.90-3.95-5.23-5.57-5.04-
Price to Earnings Ratio-55.50--36.98--21.79--20.00--12.86--10.39-
Price-to-Total Gains Ratio-8,638.88--2,144.03-1,629.83--216.57--141.30--59.57-
Price to Book Ratio14.27-11.38-6.57-8.09-16.27-13.26-
Price-to-Total Gains Ratio-8,638.88--2,144.03-1,629.83--216.57--141.30--59.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share14.45
Number of shares69
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.080.03
Usd Total Gains Per Share0.080.03
Gains per Quarter (69 shares)5.721.77
Gains per Year (69 shares)22.887.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10231307-3
2046360144
30695902111
40928202818
5011410503525
6013712804332
7016015105039
8018317405746
9020619706453
10022922007160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%5.025.00.016.7%5.025.00.016.7%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%12.018.00.040.0%12.018.00.040.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.027.010.0%3.00.027.010.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%12.018.00.040.0%12.018.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Eton Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0020.083-102%0.040-104%0.034-104%0.026-106%0.030-105%
Book Value Per Share--0.9090.730+25%0.602+51%0.595+53%0.568+60%0.541+68%
Current Ratio--1.9711.733+14%2.149-8%2.491-21%3.917-50%5.929-67%
Debt To Asset Ratio--0.7090.630+13%0.483+47%0.530+34%0.499+42%0.398+78%
Debt To Equity Ratio--2.4371.790+36%0.939+160%1.218+100%1.323+84%0.975+150%
Dividend Per Share----0%-0%-0%-0%0.003-100%
Enterprise Value--306818280.000219034238.750+40%111180831.250+176%136913883.750+124%150610399.000+104%159655833.846+92%
Eps---0.058-0.043-27%0.009-787%-0.031-47%-0.068+16%-0.137+134%
Ev To Ebitda Ratio---163.201-9.697-94%-35.341-78%-24.698-85%-16.046-90%-15.353-91%
Ev To Sales Ratio--4.4384.409+1%3.434+29%3.827+16%118.686-96%125.616-96%
Free Cash Flow Per Share--0.078-0.007+109%0.030+158%0.006+1311%-0.038+148%-0.074+195%
Free Cash Flow To Equity Per Share--0.0920.304-70%0.018+409%0.106-13%0.068+37%0.133-30%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.024----------
Intrinsic Value_10Y_min--1.688----------
Intrinsic Value_1Y_max--0.048----------
Intrinsic Value_1Y_min--0.047----------
Intrinsic Value_3Y_max--0.263----------
Intrinsic Value_3Y_min--0.249----------
Intrinsic Value_5Y_max--0.619----------
Intrinsic Value_5Y_min--0.565----------
Market Cap387512875.000+10%348980280.000238830988.750+46%105862081.250+230%140351967.083+149%149444749.000+134%135064689.333+158%
Net Profit Margin---0.091-0.104+15%-0.028-69%-0.181+99%-15.183+16592%-13.859+15136%
Operating Margin----0.0550%-0.0370%-0.1500%-14.5610%-13.3940%
Operating Ratio--1.0271.062-3%1.0320%1.151-11%15.477-93%14.105-93%
Pb Ratio15.890+10%14.27311.380+25%6.574+117%8.094+76%16.272-12%13.263+8%
Pe Ratio-61.785-11%-55.499-36.983-33%-21.793-61%-19.998-64%-12.859-77%-10.392-81%
Price Per Share14.450+10%12.9808.898+46%3.948+229%5.231+148%5.571+133%5.035+158%
Price To Free Cash Flow Ratio46.472+10%41.74414.407+190%-11.534+128%0.669+6137%-5.560+113%-5.979+114%
Price To Total Gains Ratio-9617.238-11%-8638.875-2144.033-75%1629.829-630%-216.566-97%-141.296-98%-59.571-99%
Quick Ratio--1.3341.225+9%1.981-33%2.155-38%3.330-60%5.346-75%
Return On Assets---0.019-0.026+40%0.008-337%-0.031+67%-0.095+407%-0.169+805%
Return On Equity---0.064-0.069+7%0.010-740%-0.069+7%-0.364+466%-0.381+493%
Total Gains Per Share---0.0020.083-102%0.040-104%0.034-104%0.026-106%0.033-104%
Usd Book Value--24450000.00019580250.000+25%16147000.000+51%15970916.667+53%15234850.000+60%14517266.667+68%
Usd Book Value Change Per Share---0.0020.083-102%0.040-104%0.034-104%0.026-106%0.030-105%
Usd Book Value Per Share--0.9090.730+25%0.602+51%0.595+53%0.568+60%0.541+68%
Usd Dividend Per Share----0%-0%-0%-0%0.003-100%
Usd Enterprise Value--306818280.000219034238.750+40%111180831.250+176%136913883.750+124%150610399.000+104%159655833.846+92%
Usd Eps---0.058-0.043-27%0.009-787%-0.031-47%-0.068+16%-0.137+134%
Usd Free Cash Flow--2090000.000-183000.000+109%808250.000+159%148166.667+1311%-1008450.000+148%-1971333.333+194%
Usd Free Cash Flow Per Share--0.078-0.007+109%0.030+158%0.006+1311%-0.038+148%-0.074+195%
Usd Free Cash Flow To Equity Per Share--0.0920.304-70%0.018+409%0.106-13%0.068+37%0.133-30%
Usd Market Cap387512875.000+10%348980280.000238830988.750+46%105862081.250+230%140351967.083+149%149444749.000+134%135064689.333+158%
Usd Price Per Share14.450+10%12.9808.898+46%3.948+229%5.231+148%5.571+133%5.035+158%
Usd Profit---1572000.000-1146000.000-27%228250.000-789%-868666.667-45%-1843650.000+17%-2805750.000+78%
Usd Revenue--17282000.00012081750.000+43%8576000.000+102%8917500.000+94%6547900.000+164%4400533.333+293%
Usd Total Gains Per Share---0.0020.083-102%0.040-104%0.034-104%0.026-106%0.033-104%
 EOD+4 -4MRQTTM+20 -16YOY+17 -203Y+18 -195Y+23 -1410Y+20 -19

3.3 Fundamental Score

Let's check the fundamental score of Eton Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-61.785
Price to Book Ratio (EOD)Between0-115.890
Net Profit Margin (MRQ)Greater than0-0.091
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.334
Current Ratio (MRQ)Greater than11.971
Debt to Asset Ratio (MRQ)Less than10.709
Debt to Equity Ratio (MRQ)Less than12.437
Return on Equity (MRQ)Greater than0.15-0.064
Return on Assets (MRQ)Greater than0.05-0.019
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.900
Ma 20Greater thanMa 5014.518
Ma 50Greater thanMa 10016.533
Ma 100Greater thanMa 20015.453
OpenGreater thanClose14.530
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Fundamental data was last updated by Penke on 2025-06-19 05:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Eton Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -9.1%Β means thatΒ $-0.09 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is -9.1%. The company is making a loss. -1
  • The TTM is -10.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-10.4%+1.3%
TTM-10.4%YOY-2.8%-7.6%
TTM-10.4%5Y-1,518.3%+1,507.9%
5Y-1,518.3%10Y-1,385.9%-132.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Eton Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -1.9% Return on Assets means thatΒ Eton Pharmaceuticals Inc generatedΒ $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eton Pharmaceuticals Inc:

  • The MRQ is -1.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-2.6%+0.7%
TTM-2.6%YOY0.8%-3.4%
TTM-2.6%5Y-9.5%+6.9%
5Y-9.5%10Y-16.9%+7.4%
4.3.1.3. Return on Equity

Shows how efficient Eton Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -6.4% Return on Equity means Eton Pharmaceuticals Inc generated $-0.06Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eton Pharmaceuticals Inc:

  • The MRQ is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-6.9%+0.5%
TTM-6.9%YOY1.0%-7.9%
TTM-6.9%5Y-36.4%+29.5%
5Y-36.4%10Y-38.1%+1.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Eton Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Eton Pharmaceuticals Inc is operatingΒ .

  • Measures how much profit Eton Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-5.5%+5.5%
TTM-5.5%YOY-3.7%-1.8%
TTM-5.5%5Y-1,456.1%+1,450.6%
5Y-1,456.1%10Y-1,339.4%-116.7%
4.3.2.2. Operating Ratio

Measures how efficient Eton Pharmaceuticals Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.03 means that the operating costs are $1.03 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.027. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.062. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.027TTM1.062-0.035
TTM1.062YOY1.032+0.030
TTM1.0625Y15.477-14.415
5Y15.47710Y14.105+1.372
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Eton Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.97Β means the company has $1.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.971. The company is able to pay all its short-term debts. +1
  • The TTM is 1.733. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.971TTM1.733+0.238
TTM1.733YOY2.149-0.417
TTM1.7335Y3.917-2.184
5Y3.91710Y5.929-2.012
4.4.3.2. Quick Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.33Β means the company can pay off $1.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.334. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.225. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.334TTM1.225+0.109
TTM1.225YOY1.981-0.756
TTM1.2255Y3.330-2.105
5Y3.33010Y5.346-2.016
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Eton Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Eton Pharmaceuticals IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Eton Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.71Β means that Eton Pharmaceuticals Inc assets areΒ financed with 70.9% credit (debt) and the remaining percentage (100% - 70.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.709. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.630. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.709TTM0.630+0.079
TTM0.630YOY0.483+0.147
TTM0.6305Y0.499+0.131
5Y0.49910Y0.398+0.101
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Eton Pharmaceuticals Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 243.7% means that company has $2.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 2.437. The company is just not able to pay all its debts with equity.
  • The TTM is 1.790. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.437TTM1.790+0.647
TTM1.790YOY0.939+0.851
TTM1.7905Y1.323+0.467
5Y1.32310Y0.975+0.348
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Eton Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Eton Pharmaceuticals Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -55.50 means the investor is paying $-55.50Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is -61.785. Based on the earnings, the company is expensive. -2
  • The MRQ is -55.499. Based on the earnings, the company is expensive. -2
  • The TTM is -36.983. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-61.785MRQ-55.499-6.285
MRQ-55.499TTM-36.983-18.517
TTM-36.983YOY-21.793-15.190
TTM-36.9835Y-12.859-24.124
5Y-12.85910Y-10.392-2.466
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is 46.472. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 41.744. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 14.407. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD46.472MRQ41.744+4.728
MRQ41.744TTM14.407+27.337
TTM14.407YOY-11.534+25.941
TTM14.4075Y-5.560+19.967
5Y-5.56010Y-5.979+0.419
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Eton Pharmaceuticals Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 14.27 means the investor is paying $14.27Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is 15.890. Based on the equity, the company is expensive. -2
  • The MRQ is 14.273. Based on the equity, the company is expensive. -2
  • The TTM is 11.380. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.890MRQ14.273+1.616
MRQ14.273TTM11.380+2.894
TTM11.380YOY6.574+4.806
TTM11.3805Y16.272-4.892
5Y16.27210Y13.263+3.009
4.6.2. Total Gains per Share

2.4. Latest News of Eton Pharmaceuticals Inc

Does Eton Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Eton Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-27
20:24
Sector Update: Health Care Stocks Mixed Friday AfternoonRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Eton Pharmaceuticals Inc.

4.8.1. Institutions holding Eton Pharmaceuticals Inc

Institutions are holding 53.056% of the shares of Eton Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Opaleye Management Inc10.63518.2422285207000
2025-03-31EcoR1 Capital, LLC7.23141.49319392881096855.995
2025-03-31Nantahala Capital Management, LLC4.3850.60651175951574685.138
2025-03-31Vanguard Group Inc4.10540.00031100963372563.5025
2025-03-31Cannell Capital LLC2.5782.986169136731004481.3074
2025-03-31Westside Investment Management, Inc.1.84081.3649493650-81572-14.181
2025-03-31Susquehanna International Group, LLP1.67350.001448804256478133.3559
2025-03-31Acadian Asset Management LLC1.50060.01484024284024280
2025-03-31Millennium Management LLC1.32720.0025355929217042156.2724
2025-03-31BlackRock Inc1.28780.0001345360277358.732
2025-03-31Geode Capital Management, LLC1.11210.00032982482960211.019
2025-03-31Renaissance Technologies Corp1.02170.00542740008090041.8954
2024-12-31Aristides Capital LLC0.90090.65922415874158720.7935
2025-03-31Connor Clark & Lunn Inv Mgmt Ltd0.86710.0132232532176548.2158
2025-03-31Thompson, Siegel & Walmsley LLC0.7080.04141898636182448.2853
2025-03-31Goldman Sachs Group Inc0.65340.00041752204534134.9102
2025-03-31Springbok Capital Management, LLC0.63180.1672169436145194598.9357
2025-03-31Morgan Stanley - Brokerage Accounts0.54940.00011473321341391016.7437
2025-03-31Mink Brook Asset Management LLC0.52761.9303141488-314317-68.9587
2024-12-31UBS Group AG0.50470.0003135352116335611.7421
Total 44.041517.529211810868+1694823+14.3%

4.9.2. Funds holding Eton Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.61580.0007701504197872.9025
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.45070.006438903716420.4239
2025-04-30Fidelity Extended Market Index0.53830.0068144355-6086-4.0454
2025-03-31Bridgeway Ultra-Small Company0.39551.7381106070-62692-37.1482
2025-04-30IMC US Ultra Micro Cap0.31611.63828477600
2025-03-31Extended Equity Market Fund K0.20480.005454910936720.5674
2025-04-30Fidelity Total Market Index0.17740.00084756100
2025-03-31Pleiades Small Cap Equity A0.15810.059342388-10053-19.1701
2025-05-31iShares Micro-Cap ETF0.14920.09764002000
2025-04-30Fidelity Series Total Market Index0.13320.00083572522956.8651
2025-05-31SEI Tax-Managed Small/Mid Cap F (SIMT)0.11690.09143134300
2025-03-31Northern Trust Extended Eq Market Idx0.11260.0053020523788.5457
2025-03-31NT Ext Equity Mkt Idx Fd - L0.11260.0053020523788.5457
2025-04-30Spartan Extended Market Index Pool F0.10650.00662856614245.2465
2024-12-31AAC Multi Style Global S0.10440.80428000280000
2025-03-31Bridgeway Ultra-Small Company Market0.09960.353826700-41000-60.5613
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.08220.004822049369020.0991
2025-04-30Fidelity Nasdaq Composite Index0.07220.00191937100
2025-04-30Spartan Total Market Index Pool G0.06590.00081767900
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0640.004817164261217.9494
Total 7.0764.83221897628-46258-2.4%

5.3. Insider Transactions

Insiders are holding 4.388% of the shares of Eton Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-16David KrempaSELL1022314.73
2025-06-13David KrempaSELL680014.77
2025-06-12David KrempaSELL1697714.92
2024-10-07Opaleye Management Inc.BUY112487.22
2024-10-04Opaleye Management Inc.BUY168526.77
2024-09-10Opaleye Management Inc.BUY575004.65
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets84,032
Total Liabilities59,582
Total Stockholder Equity24,450
 As reported
Total Liabilities 59,582
Total Stockholder Equity+ 24,450
Total Assets = 84,032

Assets

Total Assets84,032
Total Current Assets49,960
Long-term Assets34,072
Total Current Assets
Cash And Cash Equivalents 17,420
Net Receivables 16,400
Inventory 13,621
Other Current Assets 2,519
Total Current Assets  (as reported)49,960
Total Current Assets  (calculated)49,960
+/-0
Long-term Assets
Property Plant Equipment 180
Intangible Assets 33,880
Long-term Assets Other 12
Long-term Assets  (as reported)34,072
Long-term Assets  (calculated)34,072
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,350
Long-term Liabilities34,232
Total Stockholder Equity24,450
Total Current Liabilities
Accounts payable 4,872
Other Current Liabilities 15,606
Total Current Liabilities  (as reported)25,350
Total Current Liabilities  (calculated)20,478
+/- 4,872
Long-term Liabilities
Long term Debt 29,992
Capital Lease Obligations Min Short Term Debt87
Long-term Liabilities Other 4,153
Long-term Liabilities  (as reported)34,232
Long-term Liabilities  (calculated)34,232
+/-0
Total Stockholder Equity
Common Stock27
Retained Earnings -109,465
Other Stockholders Equity 133,888
Total Stockholder Equity (as reported)24,450
Total Stockholder Equity (calculated)24,450
+/-0
Other
Capital Stock27
Cash and Short Term Investments 17,420
Common Stock Shares Outstanding 26,886
Liabilities and Stockholders Equity 84,032
Net Debt -17,333
Net Invested Capital 54,442
Net Working Capital 24,610
Property Plant and Equipment Gross 180
Short Long Term Debt Total 87



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
0
13,443
11,712
9,646
7,525
28,327
23,017
18,244
13,507
17,072
17,241
14,559
11,395
26,319
31,186
29,906
26,606
27,465
23,196
23,046
21,520
25,030
23,928
30,932
31,526
31,740
30,794
31,823
35,841
76,123
84,032
84,03276,12335,84131,82330,79431,74031,52630,93223,92825,03021,52023,04623,19627,46526,60629,90631,18626,31911,39514,55917,24117,07213,50718,24423,01728,3277,5259,64611,71213,44300
   > Total Current Assets 
0
0
13,292
11,353
9,162
6,803
27,502
21,527
16,755
12,107
15,009
15,341
12,823
9,785
24,701
30,274
29,075
25,863
23,604
18,751
19,776
16,420
20,004
19,118
26,333
27,157
26,839
24,263
25,434
29,749
41,021
49,960
49,96041,02129,74925,43424,26326,83927,15726,33319,11820,00416,42019,77618,75123,60425,86329,07530,27424,7019,78512,82315,34115,00912,10716,75521,52727,5026,8039,16211,35313,29200
       Cash And Cash Equivalents 
0
0
13,156
11,215
8,946
6,603
26,735
19,584
14,947
11,777
12,066
12,335
10,270
7,332
21,295
25,113
25,802
22,709
14,406
15,229
17,046
13,378
16,305
14,708
21,566
22,070
21,388
16,655
17,694
20,261
14,936
17,420
17,42014,93620,26117,69416,65521,38822,07021,56614,70816,30513,37817,04615,22914,40622,70925,80225,11321,2957,33210,27012,33512,06611,77714,94719,58426,7356,6038,94611,21513,15600
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
473
205
-844
-754
48
300
303
385
5,471
796
834
1,498
1,852
2,874
3,084
3,495
3,411
4,240
4,873
5,591
5,361
16,400
16,4005,3615,5914,8734,2403,4113,4953,0842,8741,8521,4988347965,47138530330048-754-8442054730000000000
       Other Current Assets 
0
0
136
138
216
200
767
3,886
1,808
660
3,180
2,150
1,688
1,508
4,232
3,513
3,456
4,870
6,354
4,432
2,730
2,126
1,290
1,099
867
541
1,129
1,050
799
1,959
5,492
2,519
2,5195,4921,9597991,0501,1295418671,0991,2902,1262,7304,4326,3544,8703,4563,5134,2321,5081,6882,1503,1806601,8083,88676720021613813600
   > Long-term Assets 
0
0
151
359
484
722
825
1,490
1,489
1,400
2,063
1,900
1,736
1,610
1,618
912
831
743
3,861
4,445
3,270
5,100
5,026
4,810
4,599
4,369
4,901
6,531
6,389
6,092
35,102
34,072
34,07235,1026,0926,3896,5314,9014,3694,5994,8105,0265,1003,2704,4453,8617438319121,6181,6101,7361,9002,0631,4001,4891,49082572248435915100
       Property Plant Equipment 
0
0
119
203
233
268
773
1,442
1,445
1,360
1,277
1,154
1,034
917
1,003
339
299
257
219
193
150
115
260
225
195
147
150
131
255
226
209
180
1802092262551311501471952252601151501932192572993391,0039171,0341,1541,2771,3601,4451,44277326823320311900
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
725
688
650
612
575
537
500
463
3,621
4,240
3,108
4,973
4,754
4,573
4,392
4,210
4,739
6,388
6,122
5,854
0
33,880
33,88005,8546,1226,3884,7394,2104,3924,5734,7544,9733,1084,2403,6214635005375756126506887250000000000
       Other Assets 
0
0
32
156
251
454
52
48
44
40
61
58
52
81
232
36
32
23
21
12
12
12
12
0
12
0
0
0
0
0
0
0
0000000120121212122123323623281525861404448524542511563200
> Total Liabilities 
0
0
793
1,550
2,150
2,774
2,024
3,775
1,545
1,159
6,522
6,621
7,528
10,007
10,656
9,631
9,170
10,946
9,835
9,813
9,804
10,339
11,952
12,687
14,207
14,634
16,263
15,300
18,361
19,860
51,695
59,582
59,58251,69519,86018,36115,30016,26314,63414,20712,68711,95210,3399,8049,8139,83510,9469,1709,63110,65610,0077,5286,6216,5221,1591,5453,7752,0242,7742,1501,55079300
   > Total Current Liabilities 
0
0
793
947
1,134
1,197
2,024
3,656
1,459
1,107
1,963
2,051
2,739
3,219
3,794
3,199
3,106
5,360
4,558
3,482
3,812
4,661
6,461
7,494
9,588
10,393
16,241
15,300
18,216
19,734
19,947
25,350
25,35019,94719,73418,21615,30016,24110,3939,5887,4946,4614,6613,8123,4824,5585,3603,1063,1993,7943,2192,7392,0511,9631,1071,4593,6562,0241,1971,13494779300
       Short-term Debt 
0
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
5,380
5,107
4,732
0
0
0
0004,7325,1075,3801,5401,5401,3391,03370836401,4181,09274972628021915900001230000000
       Short Long Term Debt 
0
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
5,380
5,020
4,658
4,125
0
0
004,1254,6585,0205,3801,5401,5401,3391,03370836401,4181,09274972628021915900001230000000
       Accounts payable 
0
0
539
801
868
793
1,421
3,208
883
549
575
1,183
1,953
2,208
2,344
1,761
1,522
3,273
1,774
2,131
1,299
1,054
1,766
1,233
2,300
1,712
1,848
2,263
2,133
2,684
4,167
4,872
4,8724,1672,6842,1332,2631,8481,7122,3001,2331,7661,0541,2992,1311,7743,2731,5221,7612,3442,2081,9531,1835755498833,2081,42179386880153900
       Other Current Liabilities 
0
0
254
146
266
404
603
448
576
558
1,388
868
627
792
1,170
712
835
995
1,366
1,351
2,149
2,899
3,662
4,922
5,748
7,141
9,013
7,930
11,351
17,050
15,780
15,606
15,60615,78017,05011,3517,9309,0137,1415,7484,9223,6622,8992,1491,3511,3669958357121,1707926278681,38855857644860340426614625400
   > Long-term Liabilities 
0
0
0
603
1,016
1,577
1,421
119
86
52
4,559
4,570
4,789
6,788
6,862
6,432
6,064
5,586
5,277
6,331
5,992
5,678
5,491
5,193
4,619
4,241
22
0
145
126
31,748
34,232
34,23231,7481261450224,2414,6195,1935,4915,6785,9926,3315,2775,5866,0646,4326,8626,7884,7894,5704,55952861191,4211,5771,016603000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
4,540
4,570
4,587
6,496
6,532
6,183
5,856
0
0
0
0
5,678
5,384
5,107
0
0
0
0
0
0
0
0
000000005,1075,3845,67800005,8566,1836,5326,4964,5874,5704,5400000000000
       Warrants
0
0
0
0
0
21,161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000021,16100000
       Other Liabilities 
0
0
520
603
1,016
1,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000001,5771,01660352000
       Deferred Long Term Liability 
0
0
0
0
0
397
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000039700000
> Total Stockholder Equity
0
0
12,130
10,162
7,496
4,751
26,303
19,242
16,699
12,348
10,550
10,620
7,031
1,388
15,663
21,555
20,736
15,660
17,630
13,383
13,242
11,181
13,078
11,241
16,725
16,892
15,477
15,494
13,462
15,981
24,428
24,450
24,45024,42815,98113,46215,49415,47716,89216,72511,24113,07811,18113,24213,38317,63015,66020,73621,55515,6631,3887,03110,62010,55012,34816,69919,24226,3034,7517,49610,16212,13000
   Common Stock
0
0
6
6
6
6
18
18
18
18
18
21
21
21
24
24
25
25
25
25
25
25
25
26
26
26
26
26
26
26
27
27
2727262626262626262525252525252524242121211818181818666600
   Retained Earnings Total Equity0000000-101,235-105,794-103,134-104,0460000-89,058-87,042-92,158-84,471-77,967-73,237-64,188-61,492-56,527-53,278-45,868-19,80600000
   Accumulated Other Comprehensive Income 0000000000000000000-519-432-3450-17300-21,161-20,432-19,710000
   Capital Surplus 
0
0
0
0
0
3,390
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
0
0
0
0
115,202
116,187
117,009
117,934
0
0
0
0
0
0
0
0000000117,934117,009116,187115,2020000109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,1533,39000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
1,759
2,809
3,225
3,390
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
110,787
111,718
112,801
114,218
115,202
116,187
117,009
117,934
118,680
119,521
120,349
121,358
123,250
132,294
133,888
133,888132,294123,250121,358120,349119,521118,680117,934117,009116,187115,202114,218112,801111,718110,787109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,1533,3903,2252,8091,75900



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,011
Cost of Revenue-15,600
Gross Profit23,41123,411
 
Operating Income (+$)
Gross Profit23,411
Operating Expense-26,008
Operating Income-2,597-2,597
 
Operating Expense (+$)
Research Development3,255
Selling General Administrative22,753
Selling And Marketing Expenses0
Operating Expense26,00826,008
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,005
Other Finance Cost-794
Net Interest Income-1,211
 
Pretax Income (+$)
Operating Income-2,597
Net Interest Income-1,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,808-1,386
EBIT - interestExpense = -4,602
-3,808
-1,818
Interest Expense2,005
Earnings Before Interest and Taxes (EBIT)-2,597-1,803
Earnings Before Interest and Taxes (EBITDA)-1,451
 
After tax Income (+$)
Income Before Tax-3,808
Tax Provision-15
Net Income From Continuing Ops-3,823-3,823
Net Income-3,823
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses41,608
Total Other Income/Expenses Net-1,2111,211
 

Technical Analysis of Eton Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eton Pharmaceuticals Inc. The general trend of Eton Pharmaceuticals Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eton Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Eton Pharmaceuticals Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eton Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.43 < 21.10 < 21.48.

The bearish price targets are: 13.09 > 11.11 > 11.09.

Know someone who trades $ETON? Share this with them.πŸ‘‡

Eton Pharmaceuticals Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eton Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eton Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eton Pharmaceuticals Inc. The current macd is -0.74268022.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eton Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Eton Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Eton Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Eton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartEton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eton Pharmaceuticals Inc. The current adx is 27.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Eton Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Eton Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eton Pharmaceuticals Inc. The current sar is 13.24.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Eton Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eton Pharmaceuticals Inc. The current rsi is 41.90. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Eton Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartEton Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eton Pharmaceuticals Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eton Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Eton Pharmaceuticals Inc Daily Stochastic Oscillator ChartEton Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eton Pharmaceuticals Inc. The current cci is -14.57878076.

Eton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartEton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eton Pharmaceuticals Inc. The current cmo is -7.16541274.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Eton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartEton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eton Pharmaceuticals Inc. The current willr is -20.53789731.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Eton Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Eton Pharmaceuticals Inc Daily Williams %R ChartEton Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eton Pharmaceuticals Inc. The current atr is 0.90802751.

Eton Pharmaceuticals Inc Daily Average True Range (ATR) ChartEton Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eton Pharmaceuticals Inc. The current obv is 27,409,601.

Eton Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartEton Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eton Pharmaceuticals Inc. The current mfi is 63.07.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Eton Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartEton Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eton Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Eton Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.900
Ma 20Greater thanMa 5014.518
Ma 50Greater thanMa 10016.533
Ma 100Greater thanMa 20015.453
OpenGreater thanClose14.530
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Eton Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Eton Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eton Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Eton Pharmaceuticals Inc.

Receive notifications about Eton Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.